Neogenomics, Inc.
NEO
$10.10
-$0.44-4.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.42% | 5.06% | 31.11% | -88.89% | 22.63% |
| Total Depreciation and Amortization | 1.13% | -0.67% | -0.88% | -0.51% | 1.26% |
| Total Amortization of Deferred Charges | 0.27% | 0.41% | 0.28% | 0.42% | 0.14% |
| Total Other Non-Cash Items | -4.37% | -7.67% | 13.39% | 9.33% | -5.05% |
| Change in Net Operating Assets | -61.89% | -221.86% | 107.34% | -872.23% | 123.15% |
| Cash from Operations | 5.99% | -33.44% | 153.61% | -245.72% | 423.52% |
| Capital Expenditure | -7.41% | 17.43% | -134.16% | 20.86% | -65.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.80% | -64.28% | 1.40% | -17.08% | -3.36% |
| Cash from Investing | -55.49% | -148.08% | -49.65% | -15.53% | -17.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 20.00% |
| Issuance of Common Stock | 201.02% | -40.13% | 140.93% | -75.43% | 79.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.63% | -40.13% | 140.93% | -35.75% | -31.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.32% | -70.19% | 319.13% | -129.17% | 111.18% |
